Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

BACKGROUND: The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to assess its association with patient prognosis and treatment response. METHODS: We first analyzed the differential expression of NN...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Yue, Huiran, Yu, Hailin, Lu, Xin, Xue, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809740/
https://www.ncbi.nlm.nih.gov/pubmed/33446144
http://dx.doi.org/10.1186/s12885-021-07785-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809740/
https://www.ncbi.nlm.nih.gov/pubmed/33446144
http://dx.doi.org/10.1186/s12885-021-07785-w

Ejemplares similares